Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjsurg.2007.12.046 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hominin cognition: The null hypothesis.
Behav Brain Sci
January 2025
Department of Anthropology, Durham University, Durham,
The target article explores material culture datasets from three African forager groups. After demonstrating that these modern, contemporary human populations would leave scant evidence of symbolic behaviour or material complexity, it cautioned against using material culture as a barometer for human cognition in the deep past. Twenty-one commentaries broadly support or expand these conclusions.
View Article and Find Full Text PDFAusPATH: Activism influencing health policy.
Australas Psychiatry
January 2025
Senior Clinical Lecturer, Faculty of Health and Medical Science, University of Adelaide, Adelaide, SA, Australia.
Objective: To consider the role of AusPATH and its position statements on health policy in Australia.
Conclusions: As a consequence of a membership policy which admits members with lived experience as health experts, AusPATH functions as an activist organisation whilst claiming to be a professional association. There is no accreditation or endorsement underpinning AusPATH's influence on health policy in Australia.
Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus.
J Eur Acad Dermatol Venereol
January 2025
Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Article Synopsis
- * Current guidelines advise TB screening and preventive treatment prior to starting anti-TNF therapy, extending to other biologic therapies despite differing mechanisms of action.
- * New evidence suggests that some emerging therapies might not significantly raise TB reactivation risk, prompting calls to revise existing recommendations to better reflect individual patient risks and drug safety.
Outcomes of Kidney Transplants From Toxoplasma-Positive Donors: An Organ Procurement and Transplant Network Database Analysis.
Transpl Int
July 2024
Department of Pediatrics and the Center for Healthcare Policy and Research, University of California Davis Medical Center, Sacramento, CA, United States.
There is a need to reconsider the acceptance of organs from donors considered suboptimal, in the absence of data. Toxoplasma antibody-positive donors (TPD) constitute one such group. The objective of our study was to compare graft survival in deceased donor renal transplant (Tx) recipients, stratified by Toxoplasma IgG status, using the Organ Procurement and Transplantation Network (OPTN) database.
View Article and Find Full Text PDFOptimizing metformin therapy in practice: Tailoring therapy in specific patient groups to improve tolerability, efficacy and outcomes.
Diabetes Obes Metab
August 2024
Experimental and Clinical Biomedical Sciences "Mario Serio" Department, University of Florence, Florence, Italy.
Metformin is the first-line medication for type 2 diabetes. It is effective and safe, provided some caution is taken in specific populations. In patients with chronic kidney disease, metformin may provide long-term benefits, and it is a first-line therapy for diabetes, but the estimated glomerular filtration rate (eGFR) must be assessed regularly, to minimize the risk for metformin accumulation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!